APLS vs LNT · rev $1.00B vs P/E 21, rev $4.36B
Apellis Pharmaceuticals Inc (APLS) versus Alliant Energy Corp (LNT) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
Alliant Energy Corp (LNT) is a utilities - regulated electric company listed on US.
Latest reported APLS revenue for 2025-12-31 was $1.00B. Net income was $22.4M. Revenue was up 28.5% from 2024-12-31 to 2025-12-31. APLS currently screens at market cap $2.29B.
Latest reported LNT revenue for 2025-12-31 was $4.36B. Net income was $810.0M. Revenue was up 9.6% from 2024-12-31 to 2025-12-31. LNT currently screens at market cap $15.81B and trailing P/E 21.2.
APLS currently screens at market cap $2.29B. LNT currently screens at market cap $15.81B and trailing P/E 21.2.
Not investment advice. Open the APLS and LNT stock pages for the full models.
Not investment advice.